Skip to main content
OpenTrials

Clinical trial condition

Myeloproliferative Disorders

Explore clinical trials studying Myeloproliferative Disorders. Study availability and eligibility vary by location and protocol.

47 public trials 10 recruiting studies
Refine in advanced search Browse all conditions

Myeloproliferative Disorders trial results

Active, not recruiting

An Efficacy and Safety Study of Luspatercept (ACE-536) Versus Placebo in Subjects With Myeloproliferative Neoplasm-Associated Myelofibrosis on Concomitant JAK2 Inhibitor Therapy and Who Require Red Blood Cell Transfusions

NCT04717414

Conditions
Anemia, Bone Marrow Diseases, Hematologic Diseases, +5 more
Locations
  • Local Institution - 110 Los Angeles, California, United States
  • Local Institution - 135 Orlando, Florida, United States
  • Local Institution - 133 Plantation, Florida, United States
  • Local Institution - 112 Chicago, Illinois, United States
View all 185 locations
View Trial Details
Completed

A Phase 1/2 Study of CPI-0610 With and Without Ruxolitinib in Patients With Hematologic and Myeloproliferative Malignancies

NCT02158858

Conditions
Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Disease, +23 more
Locations
  • Mayo Clinic Arizona Phoenix, Arizona, United States
  • UCLA Medical Center Los Angeles, California, United States
  • Mayo Clinic Jacksonville Jacksonville, Florida, United States
  • Northwestern University - Lurie Comprehensive Cancer Center Chicago, Illinois, United States
View all 48 locations
View Trial Details
Completed

A Phase 1, Open-Label, Dose-Escalation & Expanded Cohort, Continuous IV Infusion, Multi-center Study of the Safety, Tolerability,PK & PD of EPZ-5676 in Treatment Relapsed/Refractory Patients With Leukemias Involving

NCT01684150

Conditions
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Bone Marrow Diseases, +16 more
Locations
  • Mayo Clinic Scottsdale-Phoenix Scottsdale, Arizona, United States
  • Northwestern University Chicago, Illinois, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
  • Duke University Health System Durham, North Carolina, United States
View Trial Details

Related conditions